{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:16:38Z","timestamp":1789611398337,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neurol.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T03:43:27Z","timestamp":1759203807000},"page":"975-980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chronic meningoencephalitis due to enterovirus A71 complicating rituximab therapy"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4529-2434","authenticated-orcid":false,"given":"A.","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Claud\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Martin de Fr\u00e9mont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tr\u00e9dez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0419-5532","authenticated-orcid":false,"given":"C.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.neurol.2025.09.003_bib0180","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv Ther"},{"issue":"11","key":"10.1016\/j.neurol.2025.09.003_bib0185","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1136\/ard-2024-225727","article-title":"B-cell depletion in autoimmune diseases","volume":"83","author":"Schett","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.neurol.2025.09.003_bib0190","article-title":"Enteroviruses and parechoviruses. Hayden RT, Wolk DM, Carroll KC, Tang YW, eds","volume":"4","author":"Dunn","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.neurol.2025.09.003_bib0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.medmal.2017.02.003","article-title":"Epidemiology of infectious encephalitis causes in 2016","volume":"47","author":"Boucher","year":"2017","journal-title":"Med Mal Infect"},{"issue":"2","key":"10.1016\/j.neurol.2025.09.003_bib0200","doi-asserted-by":"crossref","first-page":"e004036","DOI":"10.1136\/rmdopen-2023-004036","article-title":"Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies","volume":"10","author":"Martin De Fr\u00e9mont","year":"2024","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.neurol.2025.09.003_bib0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamaneurol.2014.4625","article-title":"Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis","volume":"72","author":"Tyler","year":"2015","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.09.003_bib0215","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1086\/345746","article-title":"Enteroviral Meningoencephalitis after anti-CD20 (Rituximab) treatment","volume":"36","author":"Quartier","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.neurol.2025.09.003_bib0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2257.2006.00751.x","article-title":"Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab","volume":"28","author":"Padate","year":"2006","journal-title":"Clin Lab Haematol"},{"issue":"4","key":"10.1016\/j.neurol.2025.09.003_bib0225","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/10428190902782210","article-title":"Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy","volume":"50","author":"Ganjoo","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.neurol.2025.09.003_bib0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2141.2009.07748.x","article-title":"Enterovirus infection of neuronal cells post-Rituximab","volume":"146","author":"Kiani-Alikhan","year":"2009","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.neurol.2025.09.003_bib0235","first-page":"221","article-title":"Enteroviral encephalitis in a patient with a marginal zone lymphoma treated with rituximab","volume":"68","author":"Schilthuizen","year":"2010","journal-title":"Neth J Med"},{"issue":"3","key":"10.1016\/j.neurol.2025.09.003_bib0240","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2141.2010.08202.x","article-title":"Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma","volume":"150","author":"Servais","year":"2010","journal-title":"Br J Haematol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2025.09.003_bib0245","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jns.2011.03.009","article-title":"Enterovirus 71 meningoencephalitis complicating rituximab therapy","volume":"305","author":"Ahmed","year":"2011","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.neurol.2025.09.003_bib0250","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3201\/eid1908.130202","article-title":"Fatal case of enterovirus 71 infection and rituximab therapy, France, 2012","volume":"19","author":"Kassab","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.neurol.2025.09.003_bib0255","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.autrev.2014.08.036","article-title":"Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature","volume":"13","author":"Levy","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.neurol.2025.09.003_bib0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.anai.2015.05.007","article-title":"Fatal Coxsackie meningoencephalitis in a patient with B-cell lymphopenia and hypogammaglobulinemia following rituximab therapy","volume":"115","author":"Palacios","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.neurol.2025.09.003_bib0265","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.0000000000004148","article-title":"Enteroviral T-cell encephalitis related to immunosuppressive therapy including rituximab","volume":"89","author":"Garzo-Caldas","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2025.09.003_bib0270","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hon.2365","article-title":"Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature","volume":"35","author":"Grisariu","year":"2017","journal-title":"Hematol Oncol"},{"issue":"8","key":"10.1016\/j.neurol.2025.09.003_bib0275","doi-asserted-by":"crossref","first-page":"e230177","DOI":"10.1136\/bcr-2019-230177","article-title":"Brainstem encephalitis caused by Coxsackie A16 virus in a rituximab-immunosuppressed patient","volume":"12","author":"Cameron Smail","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.neurol.2025.09.003_bib0280","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/practneurol-2019-002229","article-title":"Balancing immunosuppression and infection: recurrent enterovirus encephalitis in SLE","volume":"19","author":"Cheema","year":"2019","journal-title":"Pract Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.09.003_bib0285","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1097\/MPH.0000000000001077","article-title":"Enteroviral encephalitis in a child with CNS relapse of burkitt leukemia treated with rituximab","volume":"41","author":"Shaheen","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"issue":"19","key":"10.1016\/j.neurol.2025.09.003_bib0290","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/WNL.0000000000007468","article-title":"Treatment of rituximab-associated chronic CNS enterovirus using IVIg and fluoxetine","volume":"92","author":"Sham","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.09.003_bib0295","doi-asserted-by":"crossref","first-page":"e00558","DOI":"10.1016\/j.idcr.2019.e00558","article-title":"Chronic enteroviral meningoencephalitis in a patient on rituximab for the treatment of psoriatic arthritis: a case report and brief literature review","volume":"17","author":"Tellez","year":"2019","journal-title":"IDCases"},{"issue":"2","key":"10.1016\/j.neurol.2025.09.003_bib0300","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1352458520923978","article-title":"Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease","volume":"27","author":"Luciani","year":"2021","journal-title":"Mult Scler J"},{"issue":"1","key":"10.1016\/j.neurol.2025.09.003_bib0305","first-page":"37","article-title":"Viral encephalitis associated with rituximab maintenance therapy: two cases and a review of literature","volume":"78","author":"Noij","year":"2020","journal-title":"Neth J Med"},{"key":"10.1016\/j.neurol.2025.09.003_bib0310","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.18189","article-title":"Enteroviral meningoencephalitis as a complication of rituximab therapy for rheumatoid arthritis","author":"Cook","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.neurol.2025.09.003_bib0315","doi-asserted-by":"crossref","first-page":"577639","DOI":"10.1016\/j.jneuroim.2021.577639","article-title":"Enterovirus A71 causing meningoencephalitis and acute flaccid myelitis in a patient receiving rituximab","volume":"358","author":"Kapadia","year":"2021","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.neurol.2025.09.003_bib0320","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13365-021-01038-z","article-title":"Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis","volume":"28","author":"Epstein","year":"2022","journal-title":"J Neurovirol"},{"issue":"10","key":"10.1016\/j.neurol.2025.09.003_bib0325","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1111\/ene.15478","article-title":"Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis","volume":"29","author":"Vermeersch","year":"2022","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2025.09.003_bib0330","doi-asserted-by":"crossref","first-page":"e200171","DOI":"10.1212\/NXI.0000000000200171","article-title":"Chronic enterovirus meningoencephalitis in prolonged B-cell depletion after rituximab therapy: case report","volume":"10","author":"Jacksch","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"6","key":"10.1016\/j.neurol.2025.09.003_bib0335","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaip.2015.12.015","article-title":"Enteroviruses in X-linked agammaglobulinemia: update on epidemiology and therapy","volume":"4","author":"Bearden","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.neurol.2025.09.003_bib0210","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1474-4422(10)70209-X","article-title":"Clinical features, diagnosis, and management of enterovirus 71","volume":"9","author":"Ooi","year":"2010","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2025.09.003_bib0340","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.neurol.2025.09.003_bib0345","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/1750743X.2024.2382074","article-title":"Immunoglobulin therapies for primary immunodeficiency diseases (part 2): considerations for dosing strategies","volume":"16","author":"Li","year":"2024","journal-title":"Immunotherapy"},{"key":"10.1016\/j.neurol.2025.09.003_bib0350","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pediatrneurol.2016.06.014","article-title":"Treatment of chronic enterovirus encephalitis with fluoxetine in a patient with X-Linked agammaglobulinemia","volume":"64","author":"Gofshteyn","year":"2016","journal-title":"Pediatr Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725006101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725006101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:34:08Z","timestamp":1765413248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725006101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0035378725006101"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.09.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic meningoencephalitis due to enterovirus A71 complicating rituximab therapy","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}